Strategies for the Use of Poly(adenosine diphosphate ribose) Polymerase (PARP) Inhibitors in Cancer Therapy

Treatments with Poly(adenosine diphosphate ribose) polymerase (PARP) inhibitors have offered patients carrying cancers with mutated BRCA1 or BRCA2 genes a new and in many cases effective option for disease control. There is potentially a large patient population that may also benefit from PARP inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Ström, Cecilia E., Helleday, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030856/
https://www.ncbi.nlm.nih.gov/pubmed/24970153
http://dx.doi.org/10.3390/biom2040635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030856/
https://www.ncbi.nlm.nih.gov/pubmed/24970153
http://dx.doi.org/10.3390/biom2040635

Ejemplares similares